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Abstract
Interleukin 6 (IL6) is a pleiotropic cytokine that not only affects the immune system, but also plays an active role in
many physiological events in various organs. Notably, 35% of systemic IL6 originates from adipose tissues under
noninﬂammatory conditions. Here, we describe a previously unknown function of melanocortins in regulating Il6 gene
expression and production in 3T3-L1 adipocytes through membrane receptors which are called melanocortin receptors
(MCRs). Of the ﬁve MCRs that have been cloned, MC2R and MC5R are expressed during adipocyte differentiation.
a-Melanocyte-stimulating hormone (a-MSH) or ACTH treatment of 3T3-L1 adipocytes induces Il6 gene expression and
production in a time- and concentration-dependent manner via various signaling pathways including the protein kinase A,
p38 mitogen-activated protein kinase, cJun N-terminal kinase, and IkB kinase pathways. Speciﬁc inhibition of MC2R and
MC5R expression with short interfering Mc2r and Mc5r RNAs signiﬁcantly attenuated the a-MSH-induced increase of
intracellular cAMP and both the level of Il6 mRNA and secretion of IL6 in 3T3-L1 adipocytes. Finally, when injected into
mouse tail vein, a-MSH dramatically increased the Il6 transcript levels in epididymal fat pads. These results suggest that
a-MSH in addition to ACTH may function as a regulator of inﬂammation by regulating cytokine production.
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Introduction
Interleukin 6 (IL6) is a pleiotropic cytokine involved in
the regulation of the immune response, acute-phase
reaction, nervous and endocrine system function, bone
metabolism, hematopoiesis, insulin resistance, and
various human diseases (Kamimura et al. 2003).
Notably, adipose tissue has been regarded as a major
source of circulating IL6, particularly in obesity,
because 35% of systemic IL6 originates from subcu-
taneous adipocytes (Mohamed-Ali et al. 1997, Fried et al.
1998). Recent studies have demonstrated that Il6
negatively affects insulin signaling in adipocytes by
reducing expression of insulin receptor signaling
components (Rotter et al.2 0 0 3 ), by inducing the
suppressor of cytokine signaling 3 (a negative regulator
of insulin signaling; Lagathu et al. 2003, Shi et al. 2004),
and by decreasing adiponectin secretion (Fasshauer
et al. 2003, Kristiansen & Mandrup-Poulsen 2005).
Many IL6 inducers are known including IL1b, tumor
necrosis factor-a, lysophosphatidic acid, prostaglandin
E, thyroid-stimulating hormone, platelet-derived
growth factor, catecholamine, palmitate, bacterial
lipopolysaccharide (LPS), and viral infection and
associated transforming growth factor-b (Verhasselt
et al. 1997, Franchimont et al. 1999, Legrand-Poels
et al. 2000, Fang et al. 2004, Ajuwon & Spurlock 2005,
Liu et al. 2005, Tan et al. 2007, Antunes et al. 2008, Diya
et al. 2008). This is the ﬁrst time that melanocortins
induce Il6 gene expression and production through the
MCRs.
Melanocortins are generated by the proteolytic
cleavage of the precursor molecule, proopiomelano-
cortin (POMC). Differential enzymatic cleavage of
POMC by prohormone convertases results in the
production of ACTH, a-melanocyte-stimulating hor-
mone (a-MSH), b-MSH, g-MSH, and other hormones.
Even though these hormones are derived from
different regions of the precursor POMC, because
they share a core binding sequence His-Phe-Arg-Trp
(HFRW), which is required for binding and activation
of the receptors, ACTH can activate all ﬁve MCRs,
whereas a-MSH can activate all MCRs except MC2R
(Yang & Harmon 2003). a-MSH is one of the POMC
225
Journal of Molecular Endocrinology (2010) 44, 225–236 DOI: 10.1677/JME-09-0161
0952–5041/10/044–225 q 2010 Society for Endocrinology Printed in Great Britain Online version via http://www.endocrinology-journals.org
This is an Open Access article distributed under the terms of the Society for Endocrinology’s Re-use Licence which permits unrestricted non-commercial use, distribution, and
reproduction in any medium, provided the original work is properly cited.derivatives, as N-terminal region of ACTH. It seems like
a-MSH has a function that is similar to that of ACTH.
Melanocortins are recognized as pivotal components of
the hypothalamic–pituitary–adrenal (HPA) axis in
mediating response to stress. It has been postulated
that stress may be a causal factor in metabolic
syndromes such as insulin resistance, type 2 diabetes,
and hypertension via perturbation of the HPA axis
(Gohil et al. 2001, Kaufman et al. 2007). The pituitary
gland secretes critical hormones which affect many
target tissues in our body. On the other hand, adipocyte
tissue expresses receptors for many hormones includ-
ing pituitary hormones, and secretes several factors
which are called adipotropins (Schafﬂer et al. 2006). So,
adipocyte tissue is not a passive organ any longer, and
this is called hypothalamic–pituitary–adipose axis. To
date, ﬁve MCRs have been described (MC1R–MC5R).
All are coupled to stimulatory G-proteins (Gs), which
after binding to melanocortins initiate the activation of
adenylyl cyclase, ultimately resulting in the transcrip-
tion of cAMP-responsive genes (Bohm et al. 2006).
MC1R and MC2R have classically been considered to
have a role in the skin pigmentation (Schafﬂer et al.
2006) and adrenal steroidogenesis respectively (Cone
2006). MC3R and MC4R are expressed primarily in the
hypothalamus of the central nervous system (CNS).
The best characterized effects of MC3R and MC4R are
in the control of food intake, energy expenditure, and
sexual function (Wikberg & Mutulis 2008), and
disruption of Mc4r gene has been shown to cause
obesity in mice (Butler et al. 2001). Among the ﬁve
subtypes of MCRs, MC5R is a relatively ubiquitous
receptor in peripheral tissues, suggesting a direct
peripheral action for melanocortins. MC5R participates
in the control of exocrine secretions in exocrine glands
and fatty acid oxidation in skeletal muscle (Chen et al.
1997, An et al. 2007).
The melanocortin peptides ACTH, a-MSH, and
b-lipotropin have long been recognized to have
different degrees of lipolytic activity in the adipocytes
of various mammalian species (Boston 1999). ACTH
has recently been shown to inhibit leptin production in
3T3-L1 adipocytes (Norman et al. 2003) and to promote
a pro-inﬂammatory adipocytokine proﬁle (Iwen et al.
2008). However, the peripheral effects of a-MSH and
MCRs in adipocytes have not been extensively investi-
gated. In this study, we demonstrate for the ﬁrst time
that melanocortins are inducers of Il6 in 3T3-L1
adipocytes. We show that MC5R mediates the a-MSH-
induced increase in Il6 gene expression, and that MC2R
mediates the ACTH-induced increase in Il6 gene
expression via the activation of the protein kinase A
(PKA), p38 mitogen-activated protein kinase (MAPK),
cJun N-terminal kinase (JNK), and IkB kinase (IKK)
signaling pathways.
Materials and methods
3T3-L1 cell cultures
3T3-L1 cells were grown in DMEM containing 1%
penicillin/streptomycin (P/S) and 10% fetal bovine
serum (FBS) until they reach conﬂuency. They were
then differentiated with the differentiation mixture
(DMEM containing 1% P/S and 10% FBS, 500 mM
3-isobutyl-1-methylxanthine, 10 mg/ml insulin, and
1 mM dexamethasone) for 2 days as described (Jun
et al. 2006). Insulin was present for an additional 4 days,
and then, the culture medium was changed with only
DMEM (1% P/S and 10% FBS) for 2 days. Each
medium was changed every 2 days.
RNA extraction and real-time quantitative reverse
transcription-PCR
Total RNA was extracted from differentiated adipocytes
using TRIzol reagent (Invitrogen) according to the
manufacturer’s protocol. For real-time quantitative
reverse transcription (RT)-PCR, total RNA was reversely
transcribed using an ImProm-II RT system (Promega)
according to the manufacturer’s instructions. For detec-
tion and quantiﬁcation, a MyiQ real-time PCR detection
system(Bio-Rad)wasused.PCRswereperformedusinga
SYBR Premix Ex Taq II (Takara, Seoul, Republic of
Korea). PCRs were carried out in a ﬁnal volume of 20 ml
using 0.5 mM of each primer, cDNA, and 10 mlo ft h e
supplied enzyme mixture containing the DNA double-
strand-speciﬁc SYBR Green I dye for detection of PCR
products. PCRs were performed with a 3-min pre-
incubation at 95 8C followed by 40 cycles of 15 s at 95 8C
and 30 s at 60 8C. PCR products were veriﬁed by melting
curve analysis, agarose gel electrophoresis, and DNA
sequencing.
The following primers were used:
Arbp(forward,50-AAAACTCCGGTCTGGATTTATTTAG;
reverse, 50-TAATTCACACCTGGAAAATCTTTGT),
Gapdh (forward, 50-GCCATCAATGACCCCTTCATT;
reverse, 50-GCTCCTGGAAGATGGTGATGG),
Add1 (forward, 50-CATCTGTTGTAAGGTGTATTTGCTG;
reverse, 50-AGATGACTAGGGAACTGTGTGTGTT),
PPARg(forward,50-TTGCTGAACGTGAAGCCCATC-
GAGG; reverse, 50-GTCCTTGTAGATCTCCTGGAG-
CAG),
C/EBPa (forward, 50-CCATTTTATTTGGTCTTTTG-
TTTTG; reverse, 50-CTACATACACCCTTGGACAAC-
TAGG),
Pref1 (forward, 50-CATGAAAGAGCTCAACAAGAGTACC;
reverse, 50-GTTATACTGCAACAGGAGGTTCTTC),
Pai1 (forward, 50-CCTGGTCAACCACCTTAGTTA-
GATA; reverse, 50-AAATCAGAGAGAAAGAGGGA-
GAGAG),
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reverse, 50-TGCTTGCTTATTAGTGGAAAATCAT),
Mc1r (forward, 50-GATTTGGGAATTAGACAAGACCT-
TT; reverse, 50-GGACAAAGAAGTGTTCAGTAC-
CAGT),
Mc2r (forward,50-TAAAGGGACCAAATAACACATCA-
GT;reverse,50-CTTTCCTGTTTAGCACAACATTTC),
Mc3r (forward, 50-ATATTCTGTGGGAGATTGAGTGA-
AG;reverse,50-CCAACAATAATAACAACCATGACAA),
Mc4r (forward, 50-TAAGTTTGTGACTTTTGACATGG-
AA; reverse, 50-TGGAACCTTGATAAATAACAG-
GAAA),
Mc5r (forward, 50-GTAAACAGAAGATTCAACTCCCA-
GA; reverse, 50-CGTTCAGGGTAAGATTCAATA-
CAGT),
Rbp4 (forward, 50-GACAGCTACTCCTTTGTGTTTT-
CTC; reverse 50-AGAAATCTTCAAACTTCACATCCT),
Igf1 (forward, 50-GGAAAGGAAGTACATTTGAA-
GAACA; reverse, 50-TTATTTGGTAGGTGTTTC-
GATGTTT),
Igf2 (forward, 50-AAAAACAATTGGCAAAATCAAA-
TAA;reverse,50-TTACACTAAAGGTGCTTGGATAAGG),
Il6 (forward, 50-AGGCTTAATTACACATGTTC-
TCTGG; reverse, 50-TTATATCCAGTTTGGTAG-
CATCCAT),
adiponectin (forward, 50-GTTCTCTTCACCTACGAC-
CAGTATC; reverse, 50-AAAGCCAGTAAATGTA-
GAGTCGTTG),
resistin (forward, 50-ACTGACAAGAAGATCAAACAA-
GACT; reverse, 50-AGTGACACACTTTTTCTTCAC-
GAAT), and
Tnfa (forward, 50-GATTTGCTATCTCATACCAGGA-
GAA;reverse,50-AAGTCTAAGTACTTGGGCAGATTGA).
Relative value of gene expression was analyzed using
the 2C(t) method (Livak & Schmittgen 2001).
Western blot analysis
3T3-L1 adipocytes were plated in 60-mm tissue culture
dishes and treated with melanocortins for various time
periods. After treatment, the cells were washed twice
with cold PBS and then lysed with lysis buffer (250 mM
Tris–Cl (pH 6.5), 2% SDS, 4% b-mercaptoethanol,
0.02% bromophenol blue, and 10% glycerol).
Equal amounts of whole cell lysates were resolved by
12.5% SDS-PAGE and transferred to a polyvinylidene
diﬂuoride membrane. Membranes were blocked using
Tris-buffered saline with Tween 20 (TTBS, 150 mM
NaCl, 10 mM Tris–HCl, pH 8.0, and 0.05% Tween 20)
containing 5% skimmed milk for 30 min, and were then
incubated overnight with the indicated primary
antibody. After washing three times with TTBS, the
membranes were probed with HRP-conjugated second-
ary antibody to allow for the detection of the
appropriate bands using an ECL detection system
(Neuronex Co., Daegu, Republic of Korea).
Measurement of [
3H] cAMP
Intracellular cAMP generation was determined by [
3H]
cAMP competition assay in binding to cAMP-binding
protein as described previously by Jun et al. (2006)
with some modiﬁcations. To determine the cAMP
production induced by melanocortins, the 3T3-L1
adipocytes were stimulated with agonists for 20 min in
the presence of the phosphodiesterase inhibitor Ro
20–1724 (5 mM), and the reaction was quickly termi-
nated by three repeated cycles of freezing and thawing.
Thesampleswerethencentrifugedat12 000 gfor5 min
at 4 8C. The cAMP assay is based on the competition
between [
3H]-labeled cAMP and unlabeled cAMP
present in the sample for binding to a crude cAMP-
binding protein prepared from bovine adrenal cortex
according to the method of Brown et al. (1971). Bound
[
3H] cAMP in the supernatant was then determined by
liquidscintillationcounting.Eachsamplewasincubated
with 50 ml[
3H]-labeled cAMP (5 mCi) and 100 ml
binding protein for 2 h at 4 8C. Separation of protein-
bound cAMP from unbound cAMP was achieved by
absorption of free cAMP onto charcoal (100 ml),
followed by centrifugation at 12 000 g at 4 8C. The 200-
ml supernatant was then placed into an Eppendorf tube
containing 1.2 ml scintillation cocktail to measure
radioactivity. The cAMP concentration in the sample
was determined based on a standard curve and
expressed as picomoles per microgram of protein.
ELISA
Medium from differentiated 3T3-L1 cells cultured in
24-well plates was analyzed for IL6 using a kit (R&D
systems, Minneapolis, MN, USA).
RNA interference and transfection
ThesiRNASMARTpoolcontaining50 nmolofamixture
of four oligonucleotides which target mouse Mc2r and
Mc5r mRNA destruction by RISCs was purchased from
Dharmacon, Inc (Lafayette, CO, USA). Transfection of
the 3T3-L1 adipocytes with the siRNA SMART pool
oligonucleotides was carried out with a microporator
(Digital Biotechnology, Daegu, Republic of Korea)
according to the protocol provided by the company.
Animal experiment
Eight-week-oldC57BL/6Jmalemicewereobtainedfrom
the Orient Bio (Sungnam, South Korea). All the mouse
experiments were performed in the animal facility
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werekeptinindividualcagesinaroominwhichlighting
was controlled (12 h light:12 h darkness), and the
temperature was maintained at 23 8C. Mice were
sacriﬁced by cervical dislocation 0, 1, 3, and 6 h after
injecting vehicle or 1 mg/kg of a-MSH i.v. Immediately
after the mice were sacriﬁced, epididymal fat pads were
removed. Total RNA was extracted from epididymal fat
pads using TRIzol reagent (Invitrogen) according to
the manufacturer’s protocol, and then Il6 transcript
levels were measured using a real-time quantitative
RT-PCR.
Materials
a-, b-, and g-MSH, SB203580, SP600125, Bay11-7085,
H89, 6-Bnz-cAMP, forskolin, isoproterenol, and LPS
were purchased from the Sigma–Aldrich Inc. ACTH was
purchased from Phoenix Pharmaceuticals Company
Inc. (Burlingame, CA, USA).
Statistical analysis
All numerical values are given as meanGS.D. Signi-
ﬁcance of differences between mean values of two
groups was evaluated using Student’s t-test for unpaired
data as appropriate. A probability of P!0.001 or
P!0.05 was considered signiﬁcant.
Results
MCR subtypes are expressed in metabolic tissues
and 3T3-L1 adipocytes
To investigate the expression of the ﬁve MCR subtypes
in mouse metabolic tissues and 3T3-L1 adipocytes, real-
time quantitative RT-PCR was carried out using primers
speciﬁc for each subtype. Both MC2R and MC5R were
the two most abundant MCRs in all adipose tissues
(subcutaneous, retroperitoneal, and epididymal fat),
a n dt h ep a t t e r n so fM C Re x p r e s s i o ni n3 T 3 - L 1
Figure 1 Functional expressionof melanocortin receptor subtypes in mousetissues and
3T3-L1 adipocytes. (A) Real-time quantitative RT-PCR analysis of melanocortin
receptor subtypes in mouse metabolic tissues and 3T3-L1 adipocytes. Detection of
mRNA corresponding to all ﬁve Mcrs in liver, muscle, subcutaneous fat, retroperitoneal
fat, epididymal fat, and 3T3-L1 adipocytes. (B) Real-time quantitative RT-PCR analysis
of Mc2r and Mc5r during adipogenesis. The cDNAs derived from the 3T3-L1 cells which
had undergone differentiation for various time periods were ampliﬁed using speciﬁc
primers. For comparison, ﬁve differentiation-speciﬁcgenes were also analyzed: PPARg,
C/EBPa, Add1, aP2, and Pref1. The relative expression of the transcripts was
normalized to acidic ribosomal phosphoprotein P0 (Arbp) mRNA levels, and values
represent the meanGS.D. (C) Concentration-dependent effects of melanocortins on
cAMP generation. 3T3-L1 adipocytes were treated with various concentrations of
a-MSH,b-MSH, g-MSH,or ACTH for 20 min, and then cAMP productionwas measured.
The data present the meansGS.D. of triplicate samples. Each experiment was
performed independently at least three times.
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(Fig. 1A). Next, we investigated whether the levels of
Mc2r and Mc5r were changed during adipocyte
differentiation. Levels of individual transcripts were
analyzed by real-time quantitative RT-PCR during the
time course of 3T3-L1 differentiation up to 6 days post
induction. The kinetics of Mcr mRNA expression were
compared to those of several markers of adipogenesis,
including the transcription factors peroxisome
proliferator-activated receptor g (PPARg), CAAT/
enhancer-binding protein a (C/EBPa), and adipocyte
determination differentiation factor 1 (Add1), as well as
adipose lipid-binding protein (aP2). We also assayed
the kinetics of the expression of the preadipocyte
marker, preadipocyte factor 1 (Pref1; Fig. 1B). These
data indicate that adipogenesis is accompanied by the
upregulation of Mc2r and Mc5r mRNAs. MCRs are
G-protein-coupled receptors and are coupled to
adenylyl cyclase via Gs (Cone 2006). Because mRNA
expression is not necessarily correlated with protein
expression or activity, the capacities of the melanocor-
tins to stimulate cAMP production were compared in
order to characterize their pharmacological properties
in 3T3-L1 adipocytes. As shown in Fig. 1C, ACTH was
most active in elevating the level of intracellular cAMP
followed by a-MSH, b-MSH, and g-MSH. This is
consistent with the properties of the MC2R subtype,
which is selective for ACTH, and of the MC5R subtype,
which binds preferentially to a-MSH, with equal afﬁnity
to b-MSH and ACTH, and with lowest afﬁnity to g-MSH
(Cone 2006). So, a-MSH is the most potent activator
of MC5R. These data suggest that MC2R and MC5R
are functionally active in 3T3-L1 adipocytes.
Melanocortins induce Il6 expression in 3T3-L1
adipocytes
We examined the effect of a-MSH and ACTH on the
level of adipocytokines in 3T3-L1 adipocytes. Of the
adipocytokines tested, only IL6 was induced by
Figure 2 Melanocortins increase Il6 gene expression and secretion. (A) Differentiated
3T3-L1 adipocytes were incubated with a-MSH (300 nM) for 0, 1, 3, and 8 h, and various
adipocytokines including adiponectin, Il6, Rbp4, resistin, Tnfa, Pref1, Igf1, and Igf2
mRNA levels were analyzed with real-time quantitative RT-PCR using Gapdh as a
reference. Values represent the meanGS.D. of triplicate samples. (B) Differentiated
3T3-L1 adipocytes were incubated with various concentrations of ACTH. After 1 h, the
cells were harvested, and various adipocytokines including adiponectin, Il6, Pai1, Rbp4,
resistin, Tnfa, Igf1, and Igf2 mRNA levels were analyzed with real-time quantitative
RT-PCR using Gapdh as a reference. (C) Differentiated 3T3-L1 adipocytes were
stimulated with various concentrations of a-MSH. After 1 h, the cells were harvested,
and Il6 and Pai1 mRNA levels were determined using real-time quantitative RT-PCR.
(D) 3T3-L1 adipocytes were stimulated with a-MSH (300 nM), ACTH (50 nM), and LPS
(1 mg/ml) for 1, 3, and 8 h. The supernatants were collected, and IL6 concentrations
were determined by ELISA. Values represent the meansGS.D. of triplicate samples.
*P!0.05; **P!0.001 compared with the zero time point. Each experiment was
performed independently at least three times.
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Levels of Il6 mRNA were elevated within 1 h of a-MSH
treatment and returned to baseline level by 3 h, as
determined by real-time quantitative RT-PCR (Fig. 2A).
Dramatic increase of Il6 mRNA was observed when
50 nM ACTH was administered (Fig. 2B). a-MSH at a
concentration of 3–300 nM induced Il6 gene
expression in a concentration-dependent manner, but
it did not induce the expression of Pai1 (negative
control; Fig. 2C). In agreement with this ﬁnding, the
level of IL6 protein secreted into the culture medium of
3T3-L1 adipocytes increased steadily after a-MSH or
ACTH addition, and peaked at w3 h as determined by
IL6 ELISA (Fig. 2D). ACTH increased Il6 gene
expression to higher levels than seen for a-MSH, but
the proﬁle of the time course was similar to that of
a-MSH. LPS was included in the assay as a positive
control. No further increase in the level of IL6 was
detected when the experiment was extended to 24 h
(data not shown), indicating that maximal IL6 protein
production was attained by 3 h. Taken together, these
data suggest that melanocortins function as inducers of
Il6 expression in 3T3-L1 adipocytes.
PKA, p38 MAPK, JNK, and IKK signaling pathways are
involved in the melanocortin-mediated increase in Il6
gene expression and secretion
It has been reported that several stimuli including
proinﬂammatory cytokines, b2-adrenergic receptor
agonists, and adiponectin induce IL6 production
through the p38 MAPK, PKA, and NFkB signaling
pathways in various tissues and cells (Legrand-Poels
et al. 2000, Tang et al. 2007). Therefore, we investigated
the possibility that these mediators are also involved in
the signal transduction pathway leading to increased
IL6 production in a-MSH-treated 3T3-L1 adipocytes.
Pretreatment of cells with either the p38-speciﬁc
inhibitor SB203580 or the IKK inhibitor Bay11-7082
for 30 min prior to a-MSH treatment attenuated
a-MSH-induced Il6 production, whereas the JNK
inhibitor SP600125 markedly potentiated a-MSH-
induced Il6 production (Fig. 3A–C). The results suggest
that p38 MAPK and IKK signaling pathways activate
a-MSH-induced Il6 gene expression, but JNK signaling
pathway inhibits a-MSH-induced Il6 gene expression.
Western blot analysis revealed that a-MSH stimulation
Figure 3 PKA, p38 MAPK, JNK, and IKK are involved in a-MSH-induced Il6 gene
expression and secretion. Differentiated 3T3-L1 adipocytes were pretreated with A,
SB203580 (10 mM); B, SP600125 (10 mM); C, Bay 11-7085 (10 mM); and D, H89 (1 mM)
and 6-Bnz-cAMP (50 mM) for 30 min prior to treatment with a-MSH (300 nM) for 1 h.
(D) 3T3-L1 adipocytes were also treated with forskolin (3 mM), and isoproterenol (3 mM)
alone for 1 h. (E) In the presence of each inhibitor, cells were treated with a-MSH for
indicated time intervals, and culture medium was collected to measure secreted IL6.
Data represent the meansGS.D. of triplicate samples. *P!0.05; **P!0.001 compared
with the a-MSH-treated group.
#P!0.001 compared with the control group. Each
experiment was performed independently at least three times.
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MAPK, and IKK proteins in a time-dependent manner
(Fig. 4). To determine whether elevation of intra-
cellular cAMP is also necessary for Il6 induction by
a-MSH, we used a pharmacological inhibitor of the
cAMP signaling cascade. Pretreatment of 3T3-L1
adipocytes for 30 min with the PKA inhibitor H89 led
to a reduction of the a-MSH-induced increase in the
level of Il6 mRNA (Fig. 3D). Because H89 may also
inhibit kinases other than PKA in the concentration
range used here, we conﬁrmed the involvement of PKA
using the speciﬁc PKA activator 6-Bnz-cAMP, as well as
other cAMP-elevating agents including forskolin, an
activator of adenylyl cyclase, and isoproterenol, a
b-adrenergic receptor agonist. Figure 3D shows that
6-Bnz-cAMP, forskolin, and isoproterenol mimicked the
effect of a-MSH on Il6 expression in 3T3-L1 adipocytes.
Finally, we also observed these inhibitory effects on the
IL6 release in a time-dependent manner (Fig. 3E). The
same effects were observed in the ACTH-mediated Il6
gene expression pattern (Fig. 5A–D). Taken together,
these data indicate that PKA, p38 MAPK, JNK, and IKK
mediated Il6 production induced by a-MSH or ACTH
in 3T3-L1 adipocytes.
Involvement of the MC5R in the a-MSH-induced
increase in Il6 gene expression and MC2R in the
ACTH-induced increase in Il6 gene expression
To investigate the role of the MC5R subtype in the
a-MSH-mediated increase in Il6 production and of
MC2R subtype in the ACTH-mediated increase in Il6
production, we speciﬁcally inhibited MC5R expression
by RNAi using a short interfering Mc5r RNA (siMC5R)
and Mc2r RNA (siMC2R) in 3T3-L1 adipocytes (Fig. 6A
and C). Suppression of MC5R expression signiﬁcantly
attenuated the a-MSH-induced increase in Il6 mRNA
level (Fig. 6B), and suppression of MC2R expression
also signiﬁcantly attenuated the ACTH-induced
increase in Il6 mRNA level (Fig. 6D)i n3 T 3 - L 1
adipocytes. However, suppression of MC5R expression
could not attenuate the ACTH-induced increase in Il6
mRNA level, and suppression of MC2R expression
could not attenuate a-MSH-induced increase in Il6
mRNA level (data not shown). These results suggest
that MC5R is involved in the a-MSH-induced Il6
expression, and that MC2R is involved in the ACTH-
induced Il6 expression in 3T3-L1 adipocytes.
Effect of a-MSH on Il6 expression in primary fat tissue
To investigate whether a-MSH regulates Il6 expression
in primary fat tissue, the level of Il6 mRNA in
epididymal fat pads was measured. Mice were i.v.
injected with a-MSH (1 mg/kg) in the tail vein, and
Il6 mRNA level in fat pads was measured at 0, 1, 3, and
6 h after a-MSH injection. Il6 transcript level in fat pads
peaked 1 h after injection and returned rapidly to the
baseline by 6 h (Fig. 7), which correlated well with the
proﬁle of a-MSH-induced Il6 gene expression in 3T3-L1
adipocytes. These results suggest that MCRs function to
trigger Il6 expression in response to a-MSH in fat tissue.
Discussion
In contrast to the abundant data available on the
classical roles of melanocortins in processes such as skin
pigmentation, steroidogenesis, energy expenditure,
and appetite regulation in the CNS (Cone 2006), little
is known about the peripheral functions of melano-
cortins, particularly in the adipose tissues and in
melanocortin interaction with adipocytokines. It has
been reported that adipose tissues contribute as much
as 35% of the basal circulating IL6. Moreover, there is a
positive correlation between elevated IL6 and obesity
and insulin resistance (Fernandez-Real & Ricart 2003).
Here, we further characterized IL6 as a newly described
protein target of the melanocortin signaling pathway in
adipocytes. Recently, other groups (Hoch et al. 2008,
Iwen et al. 2008) reported that melanocortin induced
Il6 gene expression, which was revealed by real-time
quantitative RT-PCR analysis. In this study, we have
demonstrated that melanocortins increase Il6 gene
expression and secretion through MCRs in 3T3-L1
adipocytes and mouse epididymal fat tissue. In
addition, we have investigated knockdown effects on
each MCR. These results suggest that a-MSH-induced
Figure 4 Phosphorylation of JNK, p38 MAPK, and IKK in
response to a-MSH. Serum-starved (12 h) 3T3-L1 adipocytes
were treated with a-MSH (300 nM) for the indicated time periods.
Whole-cell extracts were analyzed by western blots of phospho-
JNK, phospho-cJUN, phospho-p38 kinases, and phospho-IKK
protein. Equal loading of protein was checked by glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) expression. Each experi-
ment was performed independently at least three times.
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and that ACTH-induced increase in Il6 production is
mediated by MC2R. PKA, p38 MAPK, JNK, and IKK
signaling pathways played important roles in the
melanocortin-mediated Il6 production.
We have demonstrated that the patterns of MCR
expression in the 3T3-L1 adipocytes are in agreement
with those of retroperitoneal, epididymal, and subcu-
taneous fat tissues. The differential expression proﬁles
of ﬁve MCRs in 3T3-L1 cells have been reported
(Norman et al. 2003). The expression pattern of
MCRs has been analyzed with RT-PCR. We also
performed RT-PCR and real-time quantitative RT-PCR.
The analysis that was applied for the proﬁle of MCRs
was applied to mouse tissues. We found and conﬁrmed
that they expressed all types of MCRs by sequencing
RT-PCR products, but of the ﬁve MCRs subtypes, MC2R
and MC5R are expressed at the highest level in all
adipose tissues. In addition to its role in the induction
of IL6, described in this study, a-MSH has a direct
effect on lipid metabolism and leptin regulation
(Hoggard et al. 2004, Harmer et al. 2008). The observed
effects of ACTH and a-MSH on IL6 expression and
secretion occur at concentrations similar to those that
induce lipolysis and inhibit leptin expression in
adipocytes. We have assumed that ACTH and a-MSH
act primarily on the MC2R and MC5R respectively
(Cone 2006), since a-MSH does not bind to MC2R
and the hierarchical arrangement of melanocortins
with regard to elevating intracellular cAMP level is
evidenced for the functional expression of MC5R in
3T3-L1 adipocytes (Fig. 1C). Finally, the MC5R knock-
down experiment conﬁrmed the involvement of
MC5R in a-MSH-induced Il6 production (Fig. 6B),
and MC2R in ACTH-induced Il6 production (Fig. 6D).
Widely considered a primary regulator of inﬂam-
mation, p38 integrates inﬂammatory responses by
regulating several aspects of target gene transcription
and translation. p38 enhances both the transcriptional
activity of NFkB via acetylation of p65 (Saha et al. 2007)
and the translation of inﬂammatory cytokines, includ-
ing IL6, via stabilization of their mRNAs by
Figure 5 PKA, p38 MAPK, JNK, and IKK are involved in ACTH-induced Il6 gene
expression. Differentiated 3T3-L1 adipocytes were pretreated with A, SB203580
(10 mM); B, SP600125 (10 mM); C, Bay 11-7085 (10 mM); and D, H89 (1 mM) for
30 min prior to treatment with ACTH (50 nM) for 1 h. Data represent the meansGS.D.
of triplicate samples. *P!0.05; **P!0.001 compared with the ACTH-treated group.
Each experiment was performed independently at least three times.
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(Zhao et al. 2008). Because MCRs are coupled to
adenylyl cyclase and several cAMP-elevating GPCR
ligands such as prostaglandin E2, thyroid-stimulating
hormone, and catecholamine have been shown to
upregulate Il6 mRNA expression in different cell lines
(Mohamed-Ali et al. 2001, Liu et al. 2005, Antunes et al.
2006), it is reasonable to hypothesize that melanocor-
tins activate Il6 production in adipocytes. The cAMP
signal transduction pathways can activate the exchange
protein directly activated by cAMP (EPAC), which acts
independently of PKA (Holz et al. 2006). However, a
speciﬁc activator of EPAC (8-CPT-20OMe-cAMP) did not
induce IL6 secretion in adipocytes (data not shown),
whereas a speciﬁc activator of PKA (6-Bnz-cAMP)
potentiated a-MSH-induced Il6 expression (Fig. 3D).
These data suggest that the PKA, but not the EPAC,
pathway is involved in the melanocortin-induced Il6
production in 3T3-L1 adipocytes.
In this study, we have described a novel pro-
inﬂammatory role for MCRs in adipocytes. IKK/NFkB
activation and JNK pathway are critical regulators of
inﬂammation, and have been reported to be necessary
for IL6 induction in many cells (Libermann &
Baltimore 1990, Tuyt et al. 1999, An et al. 2003). The
induction of IL6 has been reported. The classical
pathway of NFkB activation is controlled by the IKK
complex. Activated IKK phosphorylates IkB, which is
then ubiquitinated and rapidly degraded, allowing
NFkB to translocate from the cytoplasm to the nucleus,
where it activates gene transcription (Niederberger &
Geisslinger 2008). While the activation of the MCRs
expressed inimmune cells has been reportedto havean
anti-inﬂammatory effect, inhibiting NFkB activation
and cytokine production induced by pro-inﬂammatory
stimuli such as LPS (Yoon et al. 2003), our results
nonetheless demonstrated that the activation of MCRs
in the absence of another pro-inﬂammatory stimulus
leads to the upregulation of Il6 mRNA and protein
levels in adipocytes. JNK activation is also involved in
the expression of IL6 in human monocytes (Tuyt et al.
1999), but a-MSH-mediated JNK activation suppresses
Il6 production in adipocytes as shown in Figs 3–5.I t
seems likely that adipocytes do not share the same
regulatory pathways that have been identiﬁed in other
cell types, such as immune cells. Moreover, recent
Figure 6 a-MSH increases Il6 gene expression through MC5R, and ACTH increases
Il6 gene expression through MC2R. 3T3-L1 adipocytes were transfected for 48 h with
siRNAs targeted to the MC5Rs (siMC5Rs), or scrambled control siRNAs (siControl), and
transfected for 24 h with siRNAs targeted to the MC2Rs (siMC2Rs), or scrambled control
siRNA (siControl). (A) The MC5R-speciﬁc siRNA reduced endogenous Mc5r expression
as detected by real-time quantitative RT-PCR. Gapdh served as an internal control.
(B) 3T3-L1 adipocytes in which MC5R had been knocked down were stimulated with
a-MSH for 1 h. Il6 gene expression was evaluated by real-time quantitative RT-PCR.
(C)TheMC2R-speciﬁcsiRNAreducedendogenousMc2rexpressionasdetectedbyreal-
time quantitative RT-PCR. Gapdh served as an internal control. (D) 3T3-L1 adipocytesin
which MC2R had been knocked down were stimulated with ACTH for 1 h. Il6 gene
expression was evaluated by real-time quantitative RT-PCR. Values represent the
meansGS.D. of triplicate samples. *P!0.05; **P!0.001 compared with the siControl-
transfected group. Each experiment was performed independently at least three times.
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induction of IL6 by several transcription factors
including C/EBPa, AP1, CREB, and NFkB occurs in a
highly stimulus- or cell-speciﬁc manner (Fasshauer et al.
2003, Persson et al. 2005, Chen et al. 2006).
Since adipose tissue has recently been regarded as a
fast-acting endocrine organ within the hierarchy of the
hypothalamus and pituitary gland and because adipose
tissue expresses speciﬁc receptors for pituitary hormo-
nes and hypothalamic releasing factors at both mRNA
and protein levels (Schafﬂer et al. 2006), our ﬁndings
provide further evidence of a signiﬁcant interaction
between adipocytokines and neuropeptides such as
a-MSH and ACTH. Our ﬁndings provide evidence for
the existence of a hypothalamic–pituitary–adipose axis,
andfortheconceptof‘adipotropins’,whichdescribethe
roles of pituitary and hypothalamic hormones or
releasing factors which directly target adipocytes via
their speciﬁc receptors (Schafﬂer et al. 2006).
We have measured Il6 expression level after injection
of 1 mg/kg of a-MSH. The concentration which we
used is about 5 mM per mouse approximately based on
the blood volume which is about 6–8% of body weight.
In most cases, the range from 200 mg/kg to 10 mg/kg
for the concentration of a-MSH is commonly used. The
i.v. injection of a-MSH increased Il6 production as
shown in Fig. 7. To conﬁrm this, we administered an
abdominal injection of a-MSH of 1 mg/kg, and showed
similar results (data not shown). This result demon-
strates that a-MSH plays an important role in inducing
Il6 expression in vivo.
The physiologicalrelevance of melanocortin-induced
Il6 production in adipose tissue remains unclear.
However, pituitary melanocortins appear to have
stress-related effects on adipocyte function. Brain-
derived a-MSH is released during stress including
immobilization stress (Khorram et al. 1985), and the
melanocortinergic pathway is rapidly recruited under
conditions of emotional stress (Liu et al. 2007). In
addition, it has been suggested that in the case of
ACTH- or a-MSH-induced lipolysis in adipocytes, stress-
induced lipolysis is mediated by pituitary release of
melanocortins (Schafﬂer et al. 2006). Recently, human
visceral and subcutaneous adipocytes have also been
shown to express the corticotropin-releasing hormone
receptor types 1 and 2, which play a major role in
coordinating autonomic, cardiovascular, endocrine,
and behavioral responses to stress (Seres et al. 2004).
These data imply that adipose tissue may be a direct
peripheral target organ of stress responses. On the
other hand, recent studies have demonstrated that
the production of IL6 can be directly stimulated
by emotional depression and stressful experiences
(Kiecolt-Glaser et al. 2003). In addition, circulating
IL6 levels and secretion of IL6 from adipose
tissue correlate with insulin resistance (Kristiansen &
Mandrup-Poulsen 2005). In this sense, our data
suggest that IL6 could be a link between obesity, stress
response, and insulin resistance.
To elucidate melanocortin’s direct peripheral effects
on adipocytes under conditions of stress, in vivo
experiments addressing the role of melanocortin in
the relationship between stress responses and insulin
sensitivity are needed.
In summary, these studies provide direct evidence for
peripheral action of melanocortins on Il6 expression
and production in adipocytes, and suggest that
melanocortins may function as regulators of inﬂam-
mation by regulating cytokine production. This is the
ﬁrst time that we ﬁnd melanocortin-mediated Il6 gene
expression through adipocyte membrane receptors and
signaling pathways through a knockdown experiment
using siRNA and in vivo. In addition, our ﬁndings
provide evidence for the existence of a regulatory loop
between the HPA axis and circulating Il6.
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Figure 7 I.v. injection of a-MSH induces Il6 gene expression in
mouse epididymal fat tissue. Mice were i.v. injected via tail vein
with 200 ml sterile PBS containing 1 mg/kg a-MSH. Epididymal fat
tissue was collected at 1, 3, and 6 h after a-MSH injection. Il6
transcript levels were determined by real-time quantitative
RT-PCR. Values represent the meansGS.D., nZ3 for each time
point.
##P!0.001 compared with the control group. Each
experiment was performed independently at least three times.
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